WatchGov

Virginia bills · 2026 Regular Session

Virginia SB 278

Federal 340-B Drug Pricing Program; impacts within the Commonwealth.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Cosponsors (5)

Summary

Official abstract published by the Virginia legislature· SUMMARY AS PASSED

Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026.

Text versions

Roll-call votes

State vote data last updated Oct 15, 2026, 8:06 AM.

DateVoteResultYour legislators
Mar 5, 2026
Senate		Concur House Amendments RpassSet your home in Virginia to see
Mar 3, 2026
House		H VOTE:passSet your home in Virginia to see
Feb 26, 2026
House		Reported from Health and Human Services with amendment(s)passSet your home in Virginia to see
Feb 24, 2026
House		Subcommittee recommends reporting with amendment(s)passSet your home in Virginia to see
Feb 16, 2026
Senate		Passage RpassSet your home in Virginia to see
Feb 12, 2026
Senate		Constitutional reading dispensed RpassSet your home in Virginia to see
Feb 11, 2026
Senate		Reported from Finance and Appropriations with substitutepassSet your home in Virginia to see
Jan 29, 2026
Senate		Reported from Education and Health with substitutepassSet your home in Virginia to see

Actions